Activity Description and Learning Objectives
In this case-based activity, experts in the diagnosis and management of multiple sclerosis discuss practical issues related to personalizing care in patients with this disease.
Upon completion of this activity, participants will be able to:
- Employ updated MS phenotype descriptions and other patient-and disease-specific factors when personalizing treatment regimens in individuals with relapsing forms of MS
- Apply recent data on the efficacy, safety, and tolerability of approved disease-modifying therapies into the development of management strategies for patients with relapsing forms of multiple sclerosis
- Develop strategies to communicate key findings related to the mechanisms of action, efficacy, safety, and tolerability of various disease-modifying therapies to individuals with MS in a patient-centric manner in order to facilitate patient knowledge and shared decision making with clinicians
Target Audience
This activity has been designed to meet the educational needs of neurologists, nurse practitioners, physician assistants, nurses, and other clinicians involved in the treatment of patients with multiple sclerosis.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Release Date: June 27, 2016 Expiration Date: June 26, 2017
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the Consortium of Multiple Sclerosis Centers has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Course Director
Edward J. Fox, MD, PhD
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas
Edward J. Fox, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for Acorda Therapeutics, Inc.; Bayer Corporation; Biogen; EMD Serono, Inc.; Genentech, Inc./Roche; Novartis Pharmaceuticals Corporation; Sanofi Genzyme; and Teva Pharmaceuticals Industries, Ltd.
Grant/Research Support from Acorda Therapeutics, Inc.; Biogen; Chugai Pharma USA, LLC; EMD Serono, Inc.; Genentech, Inc./Roche; Novartis Pharmaceuticals Corporation; Opexa Therapeutics, Inc.; Sanofi Genzyme; and Teva Pharmaceuticals Industries, Ltd.
Speakers Bureau participant with Acorda Therapeutics, Inc.; Biogen; EMD Serono, Inc.; Novartis Pharmaceuticals Corporation; Sanofi Genzyme; and Teva Pharmaceuticals Industries, Ltd.
Faculty
Lori L. Mayer, DNP, MSN, RN, MSCN
Director of Medical Research Services, MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas
Lori L. Mayer, DNP, MSN, RN, MSCN, has a financial interest/relationship or affiliation in the form of:
Consultant for Biogen; Genzyme Corporation; Novartis Pharmaceuticals Corporation; sanofi-aventis U.S. LLC; and Teva Pharmaceuticals USA.
Speakers Bureau participant with Biogen; Genzyme Corporation; Novartis Pharmaceuticals Corporation; sanofi-aventis U.S. LLC; and Teva Pharmaceuticals USA.
Advisory Board for Biogen; Genzyme Corporation; Novartis Pharmaceuticals Corporation; sanofi-aventis U.S. LLC; and Teva Pharmaceuticals USA.
Medical Director
Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education
Kirk A. Tacka, PhD, has no financial interests/relationships or affiliations in relation to this activity.
This material has been reviewed by a clinician who has disclosed no relevant financial relationships.
Laurie Scudder, DNP, NP, has served as Nurse Planner for this activity. She has declared that she has no relevant financial relationships to disclose.
Credit Information
This CME/CNE activity is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and PVI, PeerView Institute for Medical Education.
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and PVI, PeerView Institute for Medical Education. The CMSC is accredited by the ACCME to provide continuing medical education for physicians.
The CMSC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Nurse Practitioner Alternatives (NPA) is accredited as a provider of continuing nurse education by the American Nurses Credentialing Center’s Commission on Accreditation.
NPA designates this enduring material for a maximum of 1.0 Continuing Nursing Education credits.
Support
This program is supported in part by independent medical educational grants from Genentech and Mylan Inc.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.